In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Piqur Therapeutics AG

www.piqur.com

Latest From Piqur Therapeutics AG

Deals Shaping the Medical Industry, February 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in February 2016.

BioPharmaceutical Medical Device

Blueprint Medicines: A New Twist On Kinase Discovery

The convergence of maturing technology, growing industry demand for combination therapy, and regulatory innovation have given rise to Blueprint Medicines, a pure-play kinase specialist that aspires to become a US-focused cancer company.

BioPharmaceutical Business Strategies

Rivalry Intensifies In Europe For Biotech Funding, Product Development

U.K. biotech companies lead Europe in terms of funds raised and products in development in the first half of 2014, but other countries in the region are not far behind.

BioPharmaceutical Europe

Series A Rounds H1 2014: Fewer Deals, Comparable Money

The money raised in Series A financings for biopharma, medtech, and diagnostics start-ups is down 8% from the same period last year, but the number of deals is down even more dramatically.

Medical Device BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Inflammation
  • Neurology, Nervous System
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Piqur Therapeutics AG
  • Senior Management
  • Vladimir Cmiljanovic, PhD, CEO
    Gaudenz von Capeller, CFO
    Doriano Fabbro, PhD, CSO
    Frances Betts, COO
    Hervé Girsault, CBO
    Ruggero Della Bitta, MD, CMO
  • Contact Info
  • Piqur Therapeutics AG
    Phone: 61 633 29 29
    Hochbergerstrasse 60C
    Basel, CH-4057
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register